References
- Avilés, A., Huerta, J., Zepeda, G., Guzmán, R. and Díaz-Maqueo, J. C. (1991). The role of maintenance therapy in the treatment of diffuse large cell lymphoma, Acta Oncol, 30, 959–964.
- Avilés, A., Díaz-Maqueo, J. C., Talavera, A., García, E. L. and Nambo, M. J. (1999). Maintenance therapy with in-terferon-α 2b improves outcome in aggressive malignant lymphoma, Hematology, 4, 381–386.
- Avilés, A., Delgado, S., Nambo, M. J., Alatriste, S. and Díaz-Maqueo, J. C. (1994). Adjuvant radiotherapy to sites of previous bulky disease in patients with stage IV diffuse large cell lymphoma, Int J Radiat Oncol Biol Phys, 30, 799–804.
- Avilés, A., Guzmán, R., Delgado, S., Nambo, M. J. and Díaz-Maqueo, J. C. (1996). Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improved the prognosis in aggressive malignant lymphoma, Am J Hematol, 52, 275–280.
- Avilés, A., Talavera, A., Díaz-Maqueo, J. C., Cleto, S., Díaz, N. R. and García, E. L. (1998). High dose chemotherapy in the treatment of poor prognosis malignant lymphoma, Hematology, 3, 229–233.
- Gianni, A. M., Bregni, M., Siena, S., Brambilla, C., Dinicula, M., Lombardi, G., Gandula, L., Tarrela, C., Pirelli, A., Ravagnani, F., Valagusa, P. and Bonadona, G. (1997). High dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-celllymphoma, N Engl J Med, 336, 1290–1297.
- Mundt, A. J., Williams, S. F. and Hallahan, D. (1997). High dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma, Int J Radiat Oncol Biol Phys, 36, 617–625.
- Nademanee, A., Molina, A., Dagis, A., Snyder, D. S., Parker, P., Stein, A., Smith, E., Planas, I., Kashyai, A., Spielberger, R., Fung, H., Wong, K. K., Somio, G., Margolin, K., Chow, W., Sniecinski, I., Vora, N., Blame, K. G., Ailand, J. and Forman, S. J. (1997). Results of high dose therapy and autologous bone marrow transplantation during remission in poor risk intermediate and high-grade lymphoma International Index high- and high-intermediate risk group, Blood, 90, 3844–3852.
- Haouin, C., Lepage, E., Gisselbrecht, A., Bastion, Y., Coiffier, B., Brice, P., Bosly, A., Duprier, B., Novel, C., Ledercio, P., Bilon, P., Gaulard, P. and Reyes, F. (1997). Benefit for autologous bone marrow transplantation over sequential chemotherapyin poor risk aggressive non-Hodgkin's lymphoma. Updated results of the prospective study LNH-82–2, J Clin Oncol, 15, 1131–1137.
- Borden, E. (1994). Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma, Sem Oncol, 21(Suppl 6), 14–22.
- Avilés, A. (1997). The role of interferon as maintenance therapy in malignant lymphoma, Med Oncol, 14, 153–157.
- Vey, N., Blaise, D., Tibelghien, P., Attal, M., Pico, J. L., Reiffers, J., Harrousseau, J. L., Fiere, D., Tabillo, A., Gabus, R., Brandely, M. and Maraninchini, P. (1996). A pilot study of autologous bone marrow transplantation followed by recombinant interleukin 2 in malignant lymphoma, Leuk Lymph, 21, 104–107.